Suppr超能文献

75岁及以上胸主动脉瘤患者自然病史与手术结果的比较研究

Comparative study of the natural history and operative outcome in patients 75 years and older with thoracic aortic aneurysm.

作者信息

Kawachi Yoshito, Nakashima Atsuhiro, Kosuga Tomokazu, Tomoeda Hiroshi, Toshima Yoshihiro, Nishimura Yosuke

机构信息

Department of Cardiovascular Surgery, Clinical Research Institute, National Kyushu Medical Center, Fukuoka, Japan.

出版信息

Circ J. 2003 Jul;67(7):592-6. doi: 10.1253/circj.67.592.

Abstract

Surgery for thoracic aortic aneurysm (TAA) in patients 75 years and older is a high risk, but data for their natural history are not available. In the present study the subjects were 62 patients with TAA aged on average 78 years (range, 75-85 years) enrolled between August 1994 and December 2001: 20 operatively treated patients (OPE) and 42 medically managed patients (MED). All of them had been included in the indication for TAA surgery at the time of consultation. Hospital mortality rates and survival rates (Kaplan-Meier method) were compared among emergency OPE, elective OPE, and MED. There were 136 total patient-years of follow-up. Actuarial survival in MED (ie, the natural history) was 83% at 1 year after consultation and 41% at 3 years. Hospital mortality rates in emergency and elective OPE were 27% (3/11) and 0% (0/9), respectively (p=0.22), and the corresponding 3-year survival rates were 44% and 83% (p=0.019). Actuarial survival in elective OPE was higher than that in MED (p=0.022), but that of emergency OPE was similar to that for MED (p=0.17). Patients aged 75 years and older with TAA should undergo an elective operation if the aneurysm diameter is larger than 6 cm and if the patient is asymptomatic and in good anatomicosurgical, physical, and social condition.

摘要

对75岁及以上的胸主动脉瘤(TAA)患者进行手术风险很高,但目前尚无关于其自然病史的数据。在本研究中,研究对象为1994年8月至2001年12月期间纳入的62例平均年龄78岁(范围75 - 85岁)的TAA患者:20例接受手术治疗的患者(OPE)和42例接受药物治疗的患者(MED)。所有患者在会诊时均被纳入TAA手术适应症。比较了急诊手术组(OPE)、择期手术组(OPE)和药物治疗组(MED)的医院死亡率和生存率(Kaplan-Meier法)。总随访时间为136患者年。药物治疗组(MED)在会诊后1年的精算生存率为83%,3年时为41%。急诊手术组(OPE)和择期手术组(OPE)的医院死亡率分别为27%(3/11)和0%(0/9)(p = 0.22),相应的3年生存率分别为44%和83%(p = 0.019)。择期手术组(OPE)的精算生存率高于药物治疗组(MED)(p = 0.022),但急诊手术组(OPE)与药物治疗组(MED)相似(p = 0.17)。年龄在75岁及以上的TAA患者,如果动脉瘤直径大于6 cm,且患者无症状,解剖手术、身体和社会状况良好,则应接受择期手术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验